1 For acute kidney injury analysis,
we excluded patients achieving acute kidney injury criteria i
2 We excluded patients detained under sections of the Mental He
3 We excluded patients if they had undergone, or were on the wa
4 We excluded patients if they had used one of the drugs during
5 We excluded patients if they were hepatitis B-co-infected or
6 For this substudy,
we excluded patients in atrial fibrillation and those with a
7 We excluded patients &
lt;18 years of age, those with an ejection
8 We excluded patients not committed to full respiratory suppor
9 We excluded patients not undergoing pPCI, transfer patients f
10 We excluded patients presenting with endocarditis.
11 We excluded patients previously treated with an agent targeti
12 We excluded patients receiving end-of-life care.
13 We excluded patients transferred from another hospital and th
14 We excluded patients undergoing electroconversion and nursing
15 We excluded patients who did not have a radiographic tumour a
16 We excluded patients who died during initial hospitalization
17 We excluded patients who died within the first 72 hr after tr
18 To minimize confounding by poor and declining health,
we excluded patients who experienced progression or died with
19 We excluded patients who had acute or recent gastrointestinal
20 We excluded patients who had dysglycemia at baseline and thos
21 We excluded patients who had end-stage kidney disease or AKI
22 We excluded patients who had previously been enrolled in the
23 We excluded patients who had previously received any haemorrh
24 We excluded patients who had received antiviral treatment in
25 We excluded patients who needed emergency medical treatment o
26 To account for perioperative mortality,
we excluded patients who survived less than 4 months after di
27 We excluded patients who underwent surgical adrenalectomy, ha
28 We excluded patients who were already taking a beta-blocker o
29 We excluded patients who were premature (gestational age, <34
30 We excluded patients whose diagnosis had changed during follo
31 We excluded patients with a non-ICU policy or with no curativ
32 We excluded patients with a radiological or clinical diagnosi
33 We excluded patients with a severe illness that might lead to
34 We excluded patients with age less than 18 years, intracerebr
35 We excluded patients with contraindications to antibiotics, p
36 We excluded patients with contraindications to both deceased
37 We excluded patients with cutaneous or non-severe systemic ma
38 We excluded patients with end-stage renal disease or solid or
39 ere able to provide verbal consent or assent were included;
we excluded patients with haemodynamic instability and those
40 We excluded patients with left main or ostial right coronary
41 We excluded patients with less than 3 years' follow-up, preva
42 We excluded patients with metastasis, node-positive disease,
43 We excluded patients with morphoeic or recurrent basal-cell c
44 We excluded patients with pre-existing risk factors for iron
45 We excluded patients with previous cancer and followed up the
46 We excluded patients with previous exposure to lithium or one
47 We excluded patients with prior implantable cardioverter-defi
48 We excluded patients with prior ocular surgery other than cat
49 We excluded patients younger than 18 years and those with adv
50 We excluded patients younger than 18 years, those with trauma